GL1X · GenesisL1 explorer

MolNFT v2 · #161083 · protein

Discovery of a Novel, Highly Potent, and Selective Thieno[3,2-d]pyrimidi -Based Cdc7 inhibitor with a Quinuclidine Moiety (TAK-931) as an Orally Active Investigational Anti-Tumor Agent

MolNFT v2 record #161083 on GenesisL1: PDB 6P5M, “Discovery of a Novel, Highly Potent, and Selective Thieno[3,2-d]pyrimidi -Based Cdc7 inhibitor with a Quinuclidine…”. Protein, 405 residues. 3D structure, sequence proof, BLAST…

PDB
6P5M
Type
protein
Length
405 residues
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.